SCHEMBL9186643

SCHEMBL9186643

CSc1ccc2c(O)cccc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.41
CYP1A2 P05177 3/20 0.39
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.38
HSD17B10 Q99714 1/20 0.38
IDO1 P14902 1/20 0.38
NPSR1 Q6W5P4 3/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 2/20 0.37
KDM4E B2RXH2 4/20 0.37
PRNP P04156 3/20 0.37
RXFP1 Q9HBX9 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29391332 0.79 METAP2 (0.52) ACHECYP1A2ALDH1A1CYP3A4CYP2C9
SCHEMBL1134896 0.79 METAP2 (0.52) ACHECYP1A2ALDH1A1CYP3A4CYP2C9
SCHEMBL29096715 0.77 ALDH1A1 (0.50) ACHECYP1A2ALDH1A1CYP3A4CYP2C9
Bromide SCHEMBL2881348 0.77 ALDH1A1 (0.50) ACHECYP1A2ALDH1A1CYP3A4CYP2C9
SCHEMBL4615123 0.74 ACHE (0.48) ACHECYP1A2ALDH1A1HPGDHSD17B10
SCHEMBL1615737 0.71 ACHE (0.45) ACHECYP1A2ALDH1A1HPGDHSD17B10
SCHEMBL1133378 0.71 BACE1 (0.60) ACHECYP1A2PLAU
SCHEMBL9184397 0.70 KDM4E (0.42) ACHECYP1A2ALDH1A1CYP3A4CYP2C9
SCHEMBL2817162 0.70 CYP1A2 (0.58) ACHECYP1A2ALDH1A1HPGDNPSR1
SCHEMBL29979791 0.70 CYP1A2 (0.58) ACHECYP1A2ALDH1A1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed